Wells Fargo’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.81M Sell
51,701
-28,051
-35% -$2.48M ﹤0.01% 2622
2025
Q4
$6.41M Buy
79,752
+6,729
+9% +$563K ﹤0.01% 2438
2025
Q3
$7.13M Buy
73,023
+40,196
+122% +$3.24M ﹤0.01% 2288
2025
Q2
$2.29M Sell
32,827
-2,666
-8% -$152K ﹤0.01% 3128
2025
Q1
$1.76M Buy
35,493
+5,424
+18% +$343K ﹤0.01% 3261
2024
Q4
$2.1M Sell
30,069
-2,038
-6% -$169K ﹤0.01% 3158
2024
Q3
$3.37M Sell
32,107
-32,762
-51% -$3.83M ﹤0.01% 2671
2024
Q2
$9.22M Buy
64,869
+34,303
+112% +$3.95M ﹤0.01% 1797
2024
Q1
$3.41M Buy
30,566
+2,295
+8% +$273K ﹤0.01% 2554
2023
Q4
$3.67M Buy
28,271
+1,370
+5% +$189K ﹤0.01% 2447
2023
Q3
$4.39M Sell
26,901
-9,711
-27% -$1.71M ﹤0.01% 2205
2023
Q2
$6.71M Buy
36,612
+10,183
+39% +$1.47M ﹤0.01% 1913
2023
Q1
$3.52M Buy
26,429
+4,344
+20% +$510K ﹤0.01% 2393
2022
Q4
$1.75M Sell
22,085
-9,279
-30% -$654K ﹤0.01% 2876
2022
Q3
$1.9M Buy
31,364
+5,788
+23% +$374K ﹤0.01% 2783
2022
Q2
$1.4M Sell
25,576
-42,908
-63% -$2.49M ﹤0.01% 3063
2022
Q1
$5.17M Buy
68,484
+10,451
+18% +$714K ﹤0.01% 2428
2021
Q4
$4.33M Buy
58,033
+998
+2% +$59.1K ﹤0.01% 2722
2021
Q3
$2.68M Buy
57,035
+3,250
+6% +$141K ﹤0.01% 3416
2021
Q2
$2.17M Sell
53,785
-36,347
-40% -$1.51M ﹤0.01% 3616
2021
Q1
$3.7M Buy
90,132
+6,639
+8% +$248K ﹤0.01% 3130
2020
Q4
$2.43M Sell
83,493
-6,043
-7% -$156K ﹤0.01% 3352
2020
Q3
$1.97M Sell
89,536
-18,697
-17% -$477K ﹤0.01% 3323
2020
Q2
$3.01M Buy
108,233
+47,610
+79% +$1.16M ﹤0.01% 2931
2020
Q1
$1.11M Buy
60,623
+2,964
+5% +$68.9K ﹤0.01% 3483
2019
Q4
$1.39M Sell
57,659
-3,963
-6% -$83.5K ﹤0.01% 3622
2019
Q3
$1.05M Buy
61,622
+5,356
+10% +$85.6K ﹤0.01% 3796
2019
Q2
$847K Sell
56,266
-9,300
-14% -$166K ﹤0.01% 3985
2019
Q1
$1.32M Buy
65,566
+4,431
+7% +$90K ﹤0.01% 3683
2018
Q4
$1.09M Buy
61,135
+4,288
+8% +$76.2K ﹤0.01% 3780
2018
Q3
$1.12M Sell
56,847
-221,604
-80% -$4.57M ﹤0.01% 3893
2018
Q2
$5.51M Buy
278,451
+78,257
+39% +$1.72M ﹤0.01% 2595
2018
Q1
$4.93M Buy
200,194
+119,402
+148% +$3.14M ﹤0.01% 2631
2017
Q4
$2.32M Buy
80,792
+36,727
+83% +$1.16M ﹤0.01% 3256
2017
Q3
$1.21M Buy
44,065
+15,493
+54% +$343K ﹤0.01% 3718
2017
Q2
$599K Buy
28,572
+1,416
+5% +$29.9K ﹤0.01% 4097
2017
Q1
$510K Sell
27,156
-605
-2% -$9.52K ﹤0.01% 4221
2016
Q4
$404K Buy
27,761
+9,018
+48% +$123K ﹤0.01% 4348
2016
Q3
$249K Buy
18,743
+8,548
+84% +$99.2K ﹤0.01% 4348
2016
Q2
$109K Buy
10,195
+1,748
+21% +$18.7K ﹤0.01% 4771
2016
Q1
$94K Buy
8,447
+703
+9% +$7.19K ﹤0.01% 4868
2015
Q4
$80K Buy
7,744
+8
+0.1% +$85 ﹤0.01% 5065
2015
Q3
$82K Sell
7,736
-1,431
-16% -$17.4K ﹤0.01% 5027
2015
Q2
$108K Buy
9,167
+7,459
+437% +$86.4K ﹤0.01% 5015
2015
Q1
$17K Buy
1,708
+418
+32% +$4.32K ﹤0.01% 5440
2014
Q4
$13K Buy
1,290
+10
+0.8% +$87 ﹤0.01% 5515
2014
Q3
$10K Sell
1,280
-1,022
-44% -$7.68K ﹤0.01% 5569
2014
Q2
$18K Buy
2,302
+2,081
+942% +$15.5K ﹤0.01% 5412
2014
Q1
$2K Hold
221
﹤0.01% 5671
2013
Q4
$2K Sell
221
-375
-63% -$3.4K ﹤0.01% 5523
2013
Q3
$5K Sell
596
-1,066
-64% -$8.64K ﹤0.01% 5265
2013
Q2
$12K Buy
+1,662
New +$9.65K ﹤0.01% 5007

Other funds holding ACLS

Wells Fargo's ACLS Position: Q1 2026 in Review

Wells Fargo reduced its Axcelis (ACLS) stake by 35% in Q1 2026, selling an estimated $2.48M and leaving 51,701 shares worth $4.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2622.

Wells Fargo first reported a position in ACLS in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.22M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Wells Fargo held 51,701 shares of Axcelis worth $4.81M as of Q1 2026.
  • Wells Fargo sold 28,051 Axcelis shares in Q1 2026, an estimated $2.48M.
  • Axcelis made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2622 holding.
  • Wells Fargo first reported a position in Axcelis in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Axcelis position peaked at $9.22M in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.